Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-0029-1246137 | DOI Listing |
Radiology
December 2024
From the Department of Medical Imaging, University Hospitals Leuven, Leuven, Belgium (B.V.B., J.D.); and Department of Medical Imaging, Jessa Ziekenhuis, Stadsomvaart 11, 3500 Hasselt, Belgium (B.V.B.).
Pan Afr Med J
April 2024
Department of Neurosurgery, Ibn Tofail Hospital, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy in Marrakech, Cadi Ayyad University, Marrakech, Morocco.
Asian J Neurosurg
June 2023
Department of Neurosurgery, Bombay Hospital & Medical Research Centre, Mumbai, Maharashtra, India.
Intracranial melanotic schwannoma is quite rare, and involvement of the trigeminal nerve is even rarer. Early diagnosis and surgical excision are the mainstays of management. These tumors have a high tendency to recur and there is high possibility of metastasis.
View Article and Find Full Text PDFAnticancer Res
April 2023
Department of Chemistry, University of New Orleans, New Orleans, LA, U.S.A.
Background/aim: Temozolomide plays a role in treating melanoma refractory to immunomodulatory and mitogen-activated protein kinase-targeted approaches, but its efficacy is limited. 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a polychlorinated pyridine cholesteryl carbonate. Its mechanism of action is considered to be via alkylation/adduct formation with N-guanine.
View Article and Find Full Text PDFIndian J Radiol Imaging
September 2022
Department of Neurosurgery, Apollo Hospitals, Sheshadripuram, Bengaluru, Karnataka, India.
Melanotic schwannoma (MS) is a rare peripheral nerve sheath tumor commonly found in the thoracic paraspinal region. It is present in an intracranial location rarely, with 18 out of 105 MS cases described in the literature. Trigeminal nerve was involved in only six of these cases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!